Oral Session

[O-20] Neuroinfection (CJD and encephalitis)

Thu. May 24, 2018 9:45 AM - 11:15 AM Room 9 (Royton Sapporo / Regent Hall （2F）)

Chair: Masahito Yamada(Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences)Commentator: Josep Dalmau(ICREA, University of Barcelona and University of Pennsylvania, USA)

+Add all to schedule

[O-20-1] Clinical significance of PSDs learned from Nation-wide Creutzfeldt Jakob Disease Surveillance

^○Yoshiyuki Kuroiwa¹, Ichirou Takumi², Hiroyuki Murai³, Kensaku Kasuga⁴, Yoshikazu Nakamura⁵, Toshiaki Hirai¹, Kimihiro Fujino¹, Yuichi Kawabata¹, Takashi Kurokawa¹, Yasuhisa Baba¹, Katsuya Satou⁶, Masafumi Harada⁷, Tetsuya Kitamoto⁸, Tadashi Tsukamoto⁹, Masahito Yamada¹⁰, Hidehiro Mizusawa⁹ (1.Department of Neurology,Teikyo University Mizonokuchi Hospital, 2.Department of Neurosurgery, Saint-Marianna Medical University, 3.Department of Neurology,International University of Health and Welfare, 4.Department of Neurology,Niigata University School of Medicine, 5.Department of Epidemiology, Jichi Medical University, 6.Department of Neurology,Nagasaki University School of Medicine, 7.Department of Radiology, Tokushima University School of Medicine, 8.Department of Pathology, Tohoku University School of Medicine, 9.Department of Neurology, National Center for Neurology and Psychiatry, 10.Department of Neurology,Kanazawa University School of Medicine)

[O-20-2] Host cell-specific TDP-43 proteinopathy and aggresomes by Theiler's murine encephalomyelitis virus

^○Katsuhisa Masaki, Yoshifumi Sonobe, Ghanashyam Ghadge, Raymond Roos (Department of Neurology, University of Chicago Medical Center)

[O-20-3] Long-term outcome of anti-NMDA receptor encephalitis in Japan

^○Hideto Nakajima (Neurology, Osaka Medical College)

[O-20-4] Proposing diagnostic criteria for MM2-cortical type sporadic Creutzfeldt-Jakob disease

^○Tsuyoshi Hamaguchi¹, Kenji Sakai¹, Nobuo Sanjo², Ryusuke Ae³, Yosikazu Nakamura³, Tetsuyuki Kitamoto⁴, Shigeo Murayama⁵, Katsuya Satoh⁶, Masafumi Harada⁷, Tadashi Tsukamoto⁸, Hidehiro Mizusawa⁸, Masahito Yamada¹ (1.Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, 2.Department of Neurology and Neurological Science, Graduate School, Tokyo Medical and Dental University, 3.Department of Public Health, Jichi Medical University, 4.Departments of Neurological Science, Graduate School of Medicine, Tohoku University, 5.Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, 6.Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Science, 7.Department of Radiologic Technology, School of Health Sciences, The University of Tokushima, 8.Department of Neurology, National Center of Neurology and Psychiatry)

[O-20-5] Inhibition of survival gene ABL1 dramatically decreases HTLV-1 infected CD4+T cells in HAM/TSP

^○Daisuke Kodama¹, Toshio Matsuzaki², Masakazu Tanaka¹, Eiji Matsuura³, Hiroshi Takashima³, Ryuji Kubota³, Shuji Izumo³ (1.Division of Molecular Pathology, Center for Chronic Virus Diseases, Kagoshima University, 2.Department of Neurology, Medical Corporation Sanshukai Ohkatsu Hospital, 3.Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences)

[O-20-6] Cerebrospinal fluid polymorphonuclear lymphocytes in diagnosis of CNS inflammation

^○Hiroshi Kuroda¹, Kimihiko Kaneko¹, Ryo Ogawa¹, Yoshiki Takai¹, Shuhei Nishiyama¹, Toshiyuki Takahashi¹, Tatsuro Misu^1,2, Ichiro Nakashima^1,3, Kazuo Fujihara^1,4, Masashi Aoki¹ (1.Department of Neurology, Tohoku University Graduate School of Medicine, 2.Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, 3.Department of Neurology, Tohoku Medical and Pharmaceutical University, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University)